By
AmyT on
September 28, 2010
Whenever I learn something new (diabetes-related), I like to share it here. Because I figure if I hadn’t heard about it — as I’m sniffing the air for D-news over the years — then lots of other PWDs out there probably haven’t heard about it yet either.
Today’s tidbit is about that famous diabetes activist Dr. Richard Bernstein, whose promotion of the utra-low-carb diet for diabetics has made him such a controversial figure.
The new…
Read more »
{Note: this two-part series is aimed as much at Pharma as at patients. If you work in the industry, please read.}
If the emphasis among diabetes systems vendors last year at the annual American Diabetes Association Conference was “data visualization,” then this year’s was “data interpretation.“ I am 100% more enthused about the latter, and I’ll tell you why.
It seemed that last year, all the big players — J&J, Medtronic, Abbott Diabetes, Roche, and…
Read more »
There were a number of encouraging news announcements this week here in Florida about progress on the JDRF’s Artificial Pancreas Project. The most prominent of those is today’s unveiling of the results of the STAR 3 Trial (Sensor-Augmented Pump Therapy for A1C Reduction) that showed adults, teens and children achieving a 4x reduction in A1C levels using this tech-heavy therapy versus patients on injections.
The STAR study, sponsored by Medtronic, was conducted at 30 clinics…
Read more »
Pelikan Sun was the ‘Cadillac’ of diabetes lancing systems — with everything that implies: excellent performance, a high-end chassis, yet expensive and impractical for most people. But for some (especially parents of type 1 kids) it was a life-altering product: a way to prick your finger a dozen times a day without feeling a thing!
When the company went out of business a few months ago, I started referring people to the Renew Lancing system…
Read more »